Industries > Pharma > Global Ophthalmic Drugs Market Forecast 2017-2027

Global Ophthalmic Drugs Market Forecast 2017-2027

Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs

PUBLISHED: 14 June 2017
PAGES: 306
PRODUCT CODE: PHA0202
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0202 Categories: , Tag:

The global ophthalmic drugs market is expected to grow at a CAGR of 4.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.6% from 2017-2027. The market is estimated at $23bn in 2016 and $28.1bn in 2021. In 2016, the retinal disorder drugs submarket held 40% of the share in this market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 306-page report you will receive 125 tables and 113 figures – all unavailable elsewhere.

The 306-page report provides clear detailed insight into the global ophthalmic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Ophthalmic Drugs market forecasts from 2017-2027

• This report also breaks down the revenue forecasts to 2027 for the global ophthalmic drugs market by the leading submarkets:
– Retinal Disorder Drugs
– Allergic, Inflammatory & Infective Drugs
– Glaucoma Drugs
– Dry Eye Drugs
– Other Ophthalmic Drugs

Global Ophthalmic Drugs Market Forecast 2017-2027

• This report includes revenue forecasts to 2027 for the following ophthalmic drugs:
– Eylea
– Lucentis
– Avastin
– Visudyne
– Jetrea
– Pataday
– Vigamox
– Patanol
– TobraDex
– Cravit
– AzaSite
– Acular
– Lumigan and Ganfort
– Xalatan/Xalacom
– Travatan/Travatan Z and DuoTrav
– Alphagan/Alphagan P and Combigan
– Azopt
– Trusopt
– Zioptan
– Cosopt
– Tapros/Taflotan
– Restasis
– Refresh
– Hyalein
– Diquas

• This report provides individual revenue forecasts to 2027 for these national markets:
– The US
– Japan
– EU5: Germany, France, the UK, Spain, Italy
– Russia
– China
– India
– Brazil
– Rest of the World

• Our study provides a SWOT analysis and discusses Porter’s Five Forces analysis that influence the global ophthalmic drugs market

• Our report provides discussion on the ophthalmic drugs that are currently in the development pipeline

• Our study discusses the selected leading companies that are the major players in the ophthalmic drugs industry:
– Novartis
– Regeneron
– Allergan
– Roche
– Valeant
– Santen
– Bayer
– Pfizer
– Senju

Visiongain’s study is intended for anyone requiring commercial analyses for the global ophthalmic drugs market. You find data, trends and predictions.

Buy our report today Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Ophthalmic Drugs Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Ophthalmic Drugs Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ

Categories

Category